PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Rafii, A.* ; Touboul, C.* ; Al Thani, H.* ; Suhre, K. ; Malek, J.A.*

Where cancer genomics should go next: A clinician's perspective.

Hum. Mol. Genet. 23, R69-R75 (2014)
Publ. Version/Full Text Volltext DOI PMC
Closed
Open Access Green as soon as Postprint is submitted to ZB.
Large-scale, genomic studies of specific tumors such as The Cancer Genome Atlas (TCGA) have provided a better understanding of the alterations of pathways involved in the development of solid tumors including glioblastoma, breast cancer, ovarian and endometrial cancers, colon cancer and lung squamous cell carcinoma. This tremendous effort of the scientific community has confirmed the view that Cancer actually represents a wide variety of diseases originating from different organs. These studies showed that TP53 and PI3KCA are the two most mutated genes in all types of cancers and that 30% to 70% of all solid tumors harbor potentially 'actionable' mutations that can be exploited for patient stratification or treatment optimization. Translation of this huge oncogenomic dataset to clinical application in personalized medicine programs is now the main challenge for the future. The gap between our basic knowledge and clinical application is still wide. Closing the gap will require translational personalized trials, which may initiate a radical change in our routine clinical practice in oncology.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
6.677
1.583
10
13
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Acute Myeloblastic-leukemia; Breast-cancer; Personalized Medicine; Colorectal-cancer; Imatinib Mesylate; Ovarian-carcinoma; Colon-cancer; Dna; Melanoma; Genes
Language english
Publication Year 2014
HGF-reported in Year 2014
ISSN (print) / ISBN 0964-6906
e-ISSN 1460-2083
Journal Human Molecular Genetics
Quellenangaben Volume: 23, Issue: R1, Pages: R69-R75 Article Number: , Supplement: ,
Publisher Oxford University Press
Publishing Place Oxford
Reviewing status Peer reviewed
Institute(s) Institute of Bioinformatics and Systems Biology (IBIS)
POF-Topic(s) 30505 - New Technologies for Biomedical Discoveries
Research field(s) Enabling and Novel Technologies
PSP Element(s) G-503700-001
PubMed ID 24833724
DOI 10.1093/hmg/ddu234
WOS ID WOS:000349825700010
Scopus ID 84906836267
Erfassungsdatum 2014-05-18
[➜Report correction]